← All companies

GTBP

GT Biopharma, Inc.

GTBP Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.31

+0.01 +4.97%

Key statistics

from XBRL data in SEC filings

Market cap

$11.1M

Revenue (TTM)

$0.00

Net income (TTM)

-$30.4M

EPS (TTM)

$-6.46

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$8.92M

Total assets

$8.11M

Gross margin

—

52-week range

$0.26 – $1.89

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Amended charter or bylaws Jun 12, 2026 8-K Delisting notice or listing-rule failure May 22, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Entered a material agreement Apr 7, 2026 10-Q/A Quarter ended 2025-06-30 Mar 6, 2026 10-Q/A Quarter ended 2025-09-30 Mar 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 2, 2026 8-K Previously issued financials not reliable Mar 2, 2026 8-K Delisting notice or listing-rule failure Nov 26, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 8-K Modified rights of security holders Sep 26, 2025 8-K Modified rights of security holders Sep 23, 2025 8-K Director or officer change Aug 29, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Shareholder vote results Jul 24, 2025 8-K Entered a material agreement; Director or officer change Jun 11, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws May 27, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Director or officer change May 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws May 13, 2025 8-K Director or officer change May 5, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 14, 2025 8-K Unregistered sale of equity Apr 4, 2025 8-K Entered a material agreement; Unregistered sale of equity Feb 26, 2025 10-K Fiscal year ended 2024-12-31 Feb 21, 2025 8-K Other events Jan 27, 2025 8-K Delisting notice or listing-rule failure Nov 27, 2024 8-K Entered a material agreement Nov 21, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Director or officer change Sep 16, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Other events Jun 27, 2024 8-K Shareholder vote results Jun 26, 2024 8-K Director or officer change Jun 7, 2024 8-K Entered a material agreement; Unregistered sale of equity May 23, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Entered a material agreement Apr 30, 2024 10-K Fiscal year ended 2023-12-31 Mar 26, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Feb 1, 2024